ARTICLE | Clinical News
Baremsis: Ph III data
April 27, 2017 9:07 PM UTC
In February, Acacia reported data from a double-blind, international Phase III trial in 705 evaluable patients with established PONV despite receiving prior antiemetic prophylaxis showing that IV Bare...
BCIQ Company Profiles